HIV-2 transmembrane protein gp36 binds to the putative cellular receptor proteins P45 and P62

Immunobiology

Volumn 201, Issue 3-4, 2000, Pages 317-322

  Chen, Ying Hua ^a   Xiao, Yi ^a   Wu, Weicheng ^a   Wang, Quinggang ^a   Luo, Guoan ^a   Dierich, Manfred P ^b  

^a TSINGHUA UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 41; MEMBRANE PROTEIN; RECEPTOR PROTEIN;

ARTICLE; B LYMPHOCYTE; CAPILLARY ELECTROPHORESIS; DISSOCIATION; ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SURFACE PLASMON RESONANCE; T LYMPHOCYTE; VIRUS CELL INTERACTION;

EID: 0033975085     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(00)80086-8     Document Type: Article

References (19)

1. BINLEY, J., and J. P. MOORE. 1997. The viral mousetrap. Nature 387: 346-348.
2. WEISSENHORN, W., A. DESSEN, S. C. HARRISON, J. J. SKEHEL, and D. C. WILEY. 1998. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387: 426-430.
3. CHAN, D. C., D. FASS, J. M. BERGER, and P. S. KIM. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89: 263-273.
4. JIANIG, S., K. LIN, and N. STRICK. 1993. HIV-1 inhibition by a peptide. Nature 365: 113.
5. NEURATH, A. R., K. LIN, and S. JIANG. 1995. Two partially overlapping antiviral peptides from the external portion of HIV type 1 glycoprotein 41, adjoining the transmembrane region, affect the glycoprotein 41 fusion domain. AIDS Research and Human ratroviruses 11: 189-190.
6. PURTSCHER, M., A. TRKOLA, G. GRUBER, A. BUCHACHER, R. PREDL, F. STEINDL, C. TAUER, R. BERGER, N. BARRETT, A. JUNGBAUER, and H. KATINGER. 1994. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res. Human Retroviruses 10: 1651-1657.
7. MUSTER, T., F. STEINDL, M. PURTSCHER, A. TRKOLA, A. KLIMA, G. HIMMLER, F. RUKER, and H. KATINGER. 1993. A conserved neutralizing epitope on gp42 of human immunodeficiency virus type I. J. Virology 67: 6642-6647.
8. CHEN, Y. H., C. EBENBICHLER, R. VORNHAGEN, T. F. SCHULZ, G. BOCK, F. STEINDL, H. KATINGER, and M. P. DJERICH. 1992. HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9, AIDS 6: 533-539.
9. CHEN, Y. H., and M. P. DIERICH. 1996. Identification of a second site in HIV-1 gp41 mediating binding to cells. Immunology Letters 52: 153-156.
10. HENDERSON, L. A., and M. N. QURESHI. 1993. A peptide inhibitor of human immunodeficience virus infection binds to novel human cell surface polypeptides. J. Biol. Chem. 268: 15 291-15297.
11. EBENBICHLER, C., C. RODER, R. VORNHAGEN, R. RATNER, and M. P. DIERICH. 1993. Cell surface proteins binding to recombinant soluble HIV-1 and HIV-2 transmembrane proteins. AIDS 7: 489-492.
12. CHEN, Y. H., A. CHRISTIANSEN, G. BÖCK, and M. P. DIERICH. 1995. HIV-2 transmembrane protein gp36 like HIV-1 gp41 binds to human lymphocytes and monocytes. AIDS 9: 1193-1194.
13. VORNHAGEN, R. W. HINDERER, H. NEBEL-SCHICKEL, J. HORN, W. PICHLER, M. FRANKE, H. WOLF, and H. H. SONNEBORN. 1990. Development of efficient HIV-specific test systems using recombinant viral antigens. Biotest Bulletin. 4: 91-96.
14. CHEN, Y. H., G. BÖCK, R. VORNHAGEN, F. STEINDL, H. KATINGER, and M. P. DIERICH. 1993. HIV-1 gp41 binds to several proteins on the human B cell line, Raji. Molecular Immunology 30: 1159-1163.
15. DUBS, M. C., D. ALTSCHUH, and M. H. V. VAN REGENMORTEL. 1991. Interaction between viruses and monoclonal antibodies studied by surface plasmon resonance. Immunology Letters 31: 59-64.
16. LIU, Z., H. QIN, and C. XIAO. 1995. Specific binding of avidin to biotin containing lipid lamella surfaces studied with monolayers and liposomes. Eur. Biophys. J. 24: 31-38.
17. LEWIS, M. G., W. R. ELKINS, and F. E. MCCUTCHAN. 1993. Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection. Vaccine 11: 1347-1355.
18. LACASSE, R. A., K. E. FOLLIS, M. TRAHEY, J. D. SCARBOROUGH, D. R. LITTMAN, and J. H. NUNBERG. 1999. Fusion-competent vaccines: broad neutralization of primary isolates of HIV. Science 283: 357-362.
19. MONTEFIORI, D. C., and J. P. MOORE. 1999. HIV vaccines: magic of the occult? Science 283: 336-337.